Change over period: —
NSE · ANUHPHR
ANUH PHARMA
-17.6% from the 52-week high · +19.0% above the low
Anuh Pharma Ltd. engages in the manufacture of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra and currently employs 159 full-time employees. The firm is engaged in the business of manufacturing active pharmaceutical ingredients (API). The firm manufactures Macrolides, Anti-TB, Anti-Bacterials, Anti-Malarial, Anti-Hypertension, Expectorant and Corticosteroids products. Its Macrolides products include Erythromycin, Erythromycin Ethyl Succinate, Erythromycin Stearate, Erythromycin Estolate, Erythromycin Propionate, Erythromycin Phosphate, Erythromycin 11,12 Carbonate and Azithromycin. Its Anti-TB products include Pyrazinamide and Isoniazid. Its Anti-Malarial products include Sulfadoxine and Pyrimethamine. Anti-Bacterials products include Chloramphenicol and Chloramphenicol Palmitate. Anti-Hypertension products include Losartan Potassium, Telmisartan and Atorvastatin Calcium. Its Expectorant product includes Ambroxol Hydrochloride. Its Quinolones product includes Moxifloxacin Hydrochloride.
The short version. Promoter holding was 71.79% in Sep 2026, up 1.88 points over 8 quarters.
1 · The price
How has the stock traded?
ANUH PHARMA trades 17.6% below its 52-week high and 19.0% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Up 1.88 pts over 8 quarters.
Up 0.09 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.91 | 69.91 | 69.91 | 71.81 | 71.81 | 71.79 | 71.79 | 71.79 | +1.88 |
| FII | 0.02 | 0.04 | 0.04 | 0 | 0 | 0.05 | 0.01 | 0.11 | +0.09 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 30.06 | 30.05 | 30.04 | 28.18 | 28.18 | 28.16 | 28.19 | 28.09 | -1.97 |
Mutual fund holdings · Oct 2026
2 schemes hold this stock
2 the month before.
- Motilal Oswal BSE Healthcare ETF0.02% of NAV
- Bandhan BSE Healthcare Index Fund0.02% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for ANUH PHARMA are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about ANUH PHARMA
What is the ANUH PHARMA share price?
ANUH PHARMA (ANUHPHR) last closed at ₹79.76, up 0.2% on the day. Its 52-week range is ₹67.00 to ₹96.74.
What is the market cap of ANUH PHARMA?
ANUH PHARMA has a market capitalisation of about ₹817 crore.
How are ANUH PHARMA's latest results?
Promoter holding was 71.79% in Sep 2026, up 1.88 points over 8 quarters.
Who owns ANUH PHARMA?
As of Sep 2026, shareholding was: Promoter 71.79%, FII 0.11%, Public 28.09%.
How many mutual funds hold ANUH PHARMA?
2 mutual fund schemes held ANUH PHARMA in October 2026. That compares with 2 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 14 Aug 2025 · Final Dividend - Rs. 1.5
- 15 Jul 2025 · Bonus issue 1:1
- 16 Aug 2024 · Final Dividend - Rs. 2.5
- 11 Aug 2023 · Final Dividend - Rs. 2
- 03 Aug 2022 · Final Dividend - Rs. 1.75
- 17 Aug 2021 · Final Dividend - Rs. 1.5
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.